Jamjoom Pharmaceuticals Factory Company (TADAWUL:4015)

Market Cap	10.98B
Revenue (ttm)	1.44B
Net Income (ttm)	435.66M
Shares Out	70.00M
EPS (ttm)	6.22
PE Ratio	25.19
Forward PE	22.36
Dividend	3.06 (1.99%)
Ex-Dividend Date	Jul 29, 2025

Volume	112,375
Average Volume	59,488
Open	156.10
Previous Close	156.80
Day's Range	155.70 - 159.60
52-Week Range	134.00 - 199.60
Beta	0.89
RSI	47.51
Earnings Date	Oct 23, 2025

About TADAWUL:4015

Jamjoom Pharmaceuticals Factory Company manufactures and markets pharmaceutical products in the Kingdom of Saudi Arabia and internationally. The company offers products human medicines, nutraceuticals, antibiotics, general analgesics, medicines for treatment of cough, allergy, asthma, heart diseases, blood pressure, diarrhea, vomiting, ulcer, and acidity, as well as various skin infections, cancer diseases, eye drops and ointments, and cosmeceuticals. Jamjoom Pharmaceuticals Factory Company was founded in 1994 and is based in Jeddah, the Kingdo...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1994
• Employees: 1,129
• Stock Exchange: Saudi Stock Exchange
• Ticker Symbol: 4015

Financial Performance

In 2024, TADAWUL:4015's revenue was 1.32 billion, an increase of 19.77% compared to the previous year's 1.10 billion. Earnings were 356.52 million, an increase of 21.93%.